clonazepam and dan 2163

clonazepam has been researched along with dan 2163 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Abaitua, I; Alonso-Ferreira, V; Hens, MJ; Posada de la Paz, M; Villaverde-Hueso, A1
López-Jornet, P; Silvestre, FJ; Silvestre-Rangil, J1

Reviews

1 review(s) available for clonazepam and dan 2163

ArticleYear
Burning mouth syndrome: a review and update.
    Revista de neurologia, 2015, May-16, Volume: 60, Issue:10

    Topics: Adult; Age Distribution; Aged; Algorithms; Amisulpride; Antidepressive Agents; Burning Mouth Syndrome; Clonazepam; Deficiency Diseases; Dentures; Duloxetine Hydrochloride; Female; Humans; Male; Menopause; Middle Aged; Mood Disorders; Nerve Fibers, Unmyelinated; Orthodontic Appliances; Sex Distribution; Sulpiride; Tongue Habits

2015

Other Studies

4 other study(ies) available for clonazepam and dan 2163

ArticleYear
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Cost-effectiveness analysis of burning mouth syndrome therapy.
    Community dentistry and oral epidemiology, 2012, Volume: 40, Issue:2

    Topics: Amisulpride; Antidepressive Agents; Burning Mouth Syndrome; Clonazepam; Cost-Benefit Analysis; Decision Trees; Dental Care; Drug Costs; Health Care Costs; Humans; Paroxetine; Sertraline; Sulpiride

2012